Richard Christopher

Chief Financial Officer, DUSA Pharmaceuticals.

Companies

Lexaria Bioscience Corp.Board member May 16, 2025 to now¹
Lexaria Bioscience Corp.Chief executive officer Sep 5, 2024 to now²
INVIVO THERAPEUTICS HOLDINGS CORP.Chief financial officer Jan 16, 2019 to Nov 21, 2022³
ICAD INCChief financial officer Nov 14, 2016 to Dec 27, 2018⁴
Lucid MotorsChief financial officer Mar 24, 2014 to Mar 24, 2014⁵
DUSA PharmaceuticalsChief financial officer Mar 29, 2006 to Dec 20, 2012⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lexaria Bioscience Corp. LEXX50,000 shares⁷$149.5K at $2.99Jul 30, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 29, 2025Bought 15,000 shares at $0.91 of Lexaria Bioscience Corp.⁷
Dec 3, 2024Bought 27,172 shares at $2.47 of Lexaria Bioscience Corp.⁸
Dec 2, 2024Bought 22,828 shares at $2.24 of Lexaria Bioscience Corp.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLexaria Bioscience Corp., Board member
2
SEC EDGARLexaria Bioscience Corp., Chief executive officer
3
SEC EDGARINVIVO THERAPEUTICS HOLDINGS CORP., Chief financial officer
4
SEC EDGARICAD INC, Chief financial officer
5
SEC EDGARLucid Motors, Chief financial officer
6
SEC EDGARDUSA Pharmaceuticals, Chief financial officer
7
SEC EDGARLexaria Bioscience Corp. shares after the filing of Jul 30, 2025
8
SEC EDGARForm 4 filed Dec 3, 2024